ornithylaspartate has been researched along with End Stage Liver Disease in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Butterworth, RF | 1 |
| Liu, CP; Yu, ZJ | 1 |
| Fehérvári, I; Gerlei, Z; Görög, D; Kóbori, L; Nemes, B | 1 |
2 review(s) available for ornithylaspartate and End Stage Liver Disease
| Article | Year |
|---|---|
L-Ornithine L-Aspartate for the Treatment of Sarcopenia in Chronic Liver Disease: The Taming of a Vicious Cycle.
Topics: Ammonia; Dipeptides; End Stage Liver Disease; Humans; Hyperammonemia; Liver; Sarcopenia; Treatment Outcome | 2019 |
[Hepatic encephalopathy and liver transplantation].
Topics: Ammonia; Anti-Infective Agents; Colon; Dipeptides; Disaccharides; End Stage Liver Disease; Evidence-Based Medicine; Gastrointestinal Agents; Hepatic Encephalopathy; Humans; Hungary; Hydrogen-Ion Concentration; Lactobacillus; Lactulose; Laxatives; Liver Cirrhosis; Liver Transplantation; Metronidazole; Neomycin; Rifamycins; Rifaximin; Severity of Illness Index; Sugar Alcohols; Systemic Inflammatory Response Syndrome; Treatment Outcome | 2012 |
1 trial(s) available for ornithylaspartate and End Stage Liver Disease
| Article | Year |
|---|---|
[Study on L-Ornithine-L-Aspartate in the treatment of acute-on-chronic liver failure].
Topics: Dipeptides; End Stage Liver Disease; Female; Hepatitis B virus; Humans; Male | 2011 |